Gene · 5378
Papers1,886
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,886
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Application of Multigene Panels Testing for Hereditary Cancer Syndromes. | Biology (Basel) | 2022 | 36290365 | PubTator, text mining | PubMed |
| Prognostic Role of DNA Damage Response Genes Mutations and their Association With the Sensitivity of Olaparib in Prostate Cancer Patients. | Cancer Control | 2022 | 36283420 | PubTator, text mining | PubMed |
| Identification and Validation of a DNA Damage Repair-Related Signature for Diffuse Large B-Cell Lymphoma. | Biomed Res Int | 2022 | 36281462 | PubTator, text mining | PubMed |
| The Roles of EXO1 and RPA1 Polymorphisms in Prognosis of Lung Cancer Patients Treated with Platinum-Based Chemotherapy. | Dis Markers | 2022 | 36277983 | PubTator, text mining | PubMed |
| Proteomics and liquid biopsy characterization of human EMT-related metastasis in colorectal cancer. | Front Oncol | 2022 | 36249004 | PubTator, text mining | PubMed |
| A nomogram and risk classification model predicts prognosis in Chinese esophageal squamous cell carcinoma patients. | Transl Cancer Res | 2022 | 36237263 | PubTator, text mining | PubMed |
| Current Immune Checkpoint Inhibitor Genetic Biomarker Exploration in Gastrointestinal Tumors. | Cancers (Basel) | 2022 | 36230726 | PubTator, text mining | PubMed |
| Expression Profiles and Functional Analysis of Plasma Exosomal Circular RNAs in Acute Myocardial Infarction. | Biomed Res Int | 2022 | 36221294 | PubTator, text mining | PubMed |
| The unstructured linker of Mlh1 contains a motif required for endonuclease function which is mutated in cancers. | Proc Natl Acad Sci U S A | 2022 | 36215471 | PubTator, text mining | PubMed |
| Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis. | Front Pharmacol | 2022 | 36210836 | PubTator, text mining | PubMed |
| Diagnosis and clinical implication of collision gastric adenocarcinomas: a case report. | Surg Case Rep | 2022 | 36207547 | PubTator, text mining | PubMed |
Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations. | Ther Adv Med Oncol | 2022 | 36199621 | PubTator, text mining | PubMed |
| Potential of six-transmembrane epithelial antigen of the prostate 4 as a prognostic marker for colorectal cancer. | World J Gastrointest Oncol | 2022 | 36187390 | PubTator, text mining | PubMed |
| Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: A case report. | Medicine (Baltimore) | 2022 | 36181052 | PubTator, text mining | PubMed |
| Mlh1 interacts with both Msh2 and Msh6 for recruitment during mismatch repair. | DNA Repair (Amst) | 2022 | 36122480 | PubTator, text mining | PubMed |
| Microarray and in silico analysis of DNA repair genes between human testis of patients with nonobstructive azoospermia and normal cells. | Cell Biochem Funct | 2022 | 36121211 | PubTator, text mining | PubMed |
| Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients. | Front Oncol | 2022 | 36119527 | PubTator, text mining | PubMed |
| Validity of a two-antibody testing algorithm for mismatch repair deficiency testing in cancer; a systematic literature review and meta-analysis. | Mod Pathol | 2022 | 36104536 | PubTator, text mining | PubMed |
| Proteomic and functional characterization of intra-tumor heterogeneity in human endometrial cancer. | Cell Rep Med | 2022 | 36103879 | PubTator, text mining | PubMed |
| Comprehensive analyses identify RIPOR2 as a genomic instability-associated immune prognostic biomarker in cervical cancer. | Front Immunol | 2022 | 36091054 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5378/papers?page=14